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Introduction: An association between pollen count (Poaceae) and symptoms is well known, but to a lesser degree
the importance of priming and lag effects. Also, threshold levels for changes in symptom severity need to be
validated. The present study aims to investigate the relationship between pollen counts, symptoms and health
related quality of life (HRQL), and to validate thresholds levels, useful in public pollen warnings.
Material and methods: Children aged 7–18 with grass pollen allergy filled out a symptom diary during the pollen
season for nose, eyes and lung symptoms, as well as a HRQL questionnaire every week. Pollen counts were
monitored using a volumetric spore trap.
Results: 89 (91%) of the included 98 children completed the study. There was a clear association between pollen
count, symptom severity and HRQL during the whole pollen season, but no difference in this respect between early
and late pollen season. There was a lag effect of 1–3 days after pollen exposure except for lung symptoms. We
found only two threshold levels, at 30 and 80 pollen grains/m3 for the total symptom score, not three as is used
today. The nose and eyes reacted to low doses, but for the lung symptoms, symptom strength did hardly change
until 50 pollen grains/m3.
Conclusion: Grass pollen has an effect on symptoms and HRQL, lasting up to 5 days after exposure. Symptoms
from the lungs appear to have higher threshold levels than the eyes and the nose. Overall symptom severity does
not appear to change during the course of season. Threshold levels need to be revised. We suggest a traffic light
model for public pollen warnings directed to children, where green signifies “no problem”, yellow signifies “can be
problems, especially if you are highly sensitive” and red signifies “alert – take action”.
Keywords: Grass pollen allergy, Rhinoconjunctivitis, Asthma, Quality of life, Children, Pollen forecastsIntroduction
Allergic diseases like rhinoconjunctivitis, asthma and
eczema are major health problems in the western popu-
lation. Although the diseases traditionally defined by the
major target organ of the allergic inflammation, they are
tightly linked. The allergic inflammation has compo-
nents that can give rise to systemic disease manifesta-
tions [1, 2] E.g., 80 per cent of children with atopic
dermatitis will eventually have asthma or rhinitis [3]. 30* Correspondence: Hampus.Kiotseridis@med.lu.se
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reproduction in any medium, provided the orper cent of children with rhinitis have asthma, and more
than 80 per cent of children with asthma have rhinitis
symptoms [4].
Airborne pollen is one of the most common triggers
of allergic disease. They are formed by flowering plants,
among which some are especially prone cause to allergic
disease [5]. These pollen grains contain allergens that
trigger the allergic inflammatory response via mast cell
activation in the human mucosa of the target organs,
which then give rise to a systemic reaction.
Pollen that gives rise to human disease is present in
the air in northern Europe at least 6 months every year.
This fact has great implications for children affected,
and interferes in many aspects of their daily lives - notral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Kiotseridis et al. Clinical and Translational Allergy 2013, 3:19 Page 2 of 11
http://www.ctajournal.com/content/3/1/19only physical and practical but also emotional [6]. The
HRQL is an important aspect that should be taken into
account in the clinical follow up and is recommended to
be included in clinical studies [7]. Atmospheric pollen
counts are considered to be positively correlated with
allergic symptomatology [8]. This has then been con-
firmed in numerous studies [9-12] but the delay of
symptoms after the exposure, the impact of earlier
exposure (priming and lag effects) and possible changes
in reaction patterns during the course of the season have
been less often described, just as differences in reaction
patterns between different organs.
The first line treatment in respiratory allergy is allergy
avoidance [13]. Pollen warnings are meant to be part of a
guided self-management to prevent system aggravation and
help the allergy sufferers take the control of the condition.
They increase awareness about the disease and its connec-
tion to ambient aeroallergen levels, and thus act in patient
education. Pollen warnings should be presented to the pub-
lic in a structured, easily understandable way.
The aim was to study the effect of grass pollen expos-
ure on symptoms and HRQL during the grass pollen
season, and to validate the threshold values for pollen
concentration, used in pollen warnings for children.
Material and methods
Children aged 7–18 with grass pollen allergy were con-
secutively selected from May 2009-01-01 until 2009-03-
31. The majority of patients included in the study lived
in the inner city of Malmö. Some lived in the suburban
areas. Most of the children were seeing a paediatrician
because of their allergy. Most of them were seeking help
because of rhinoconjunctivitis, asthma or both.
The diagnosis of grass pollen allergy was, in addition
to the clinical history, ascertained by a positive skin
prick test or by the presence of allergy specific IgE in the
blood.
Patients were excluded if they had allergic symptoms
caused by other allergens during the grass pollen season.
The children filled out a HRQL questionnaire at the
end of the week for every week until mid-July. Every day
during the study period (1st June – 12rd July) they filled
out a diary for symptom severity. All were completed by
the children themselves. The study was approved by the
local ethics committee and informed consent was
obtained from parents and subjects.
The study protocol was approved by the Coordinating
Ethics Committee of Lund University.
Severity assessment
For the classification of rhinitis we used the ARIA (Al-
lergic Rhinitis and its Impact on Asthma) guidelines
[13]. These guidelines classify rhinitis as intermittent al-
lergic rhinitis or persistent allergic rhinitis (PAR), on thebasis of the duration of symptoms. The ARIA classifica-
tion also classifies the severity on the basis of the pres-
ence or absence of impairment in any of 4 health-related
quality of life (HRQL) items: sleep, daily activities/sport,
work/school, and troublesome symptoms. According to
guidelines the rhinitis was defined as mild when there
was no impairment in any of these items, and moder-
ate/severe when there was impairment in 1 or more
areas [13].
For the asthma severity assessment the guidelines of
the Swedish society of paediatric allergology based on
medication level were used [14].
HRQL
As a measure of HRQL the Pediatric allergic disease
quality of life questionnaire (PADQLQ) was used. The
total score covers three domains: a practical a physical
and an emotional domain. The questions are answered
with a figure (0–6) where 0 means “not troubled at all”
and 6 means extremely troubled. The minimal important
difference of the total score (0–6) is 0.2[15]. The instru-
ment is validated and used in English and Swedish
[16, 17] The questions were answered by the child.
Symptom scores
The children used a symptom diary for assessing severity
on a daily basis on symptoms from eye, nose and lungs.
The severity scale included four categories: no symptoms
(0), mild symptoms [1], moderate symptoms [2] and
severe symptoms [3].
Pollen counts
Daily atmospheric pollen counts for the Malmö area,
comprising mainly urban and agricultural land in the
North-European nemoral vegetation zone, were moni-
tored during the pollen season 2009 using a Burkard 7-
day volumetric spore trap, situated at a roof top about
25 m above ground at Skåne University Hospital (SUS),
55˚60’N, 13˚00’E. The exposed tapes were analysed by
Botaniska Analysgruppen i Göteborg AB. The counts are
representative for an area with a radius of 30 km from
the trap, encompassing the residence of all subjects in
the study.
Statistical methods
To estimate the association between pollen counts symp-
toms, HRQL and lag effects mixed models on repeated ob-
servations were performed. Three different symptoms
(nose, eye and lung), the mean of the three different symp-
toms (total) and HRQL were used as outcome. The out-
comes were on ordinal scales; the symptoms 0–3 and
HRQL 0–6. The pollen counts were tested as fixed effect
and were analysed both as continuous and categorical vari-
ables (threshold levels). Lag effects were also tested. The





Rhinoconjunctivitis and asthma (n = 89)
Age 13 (7–18) 0
Rhinitis 89.8 1
Food allergy 39.1 2
Asthma 60.2 1
Eczema 37.2 3







Affected sleep 71.2 6
Affected school performance 62.9 9
Troublesome symptoms 97.3 5
Daily activity 81.7 8
Multiple sensitisation 61.1 7
Immunotherapy 3.8 0
Oral steroid 0.0 0
Antihistamine 93.7 0
Antihistamine nose 16.5 0
Nasal steroid 53.2 0
Antihistamine eye 45.6 0
Cromoglycate eye 28.2 1
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and on three sub-periods (day 8–17, 18–27 and day
28–37). The change in reactivity to pollen exposure during
the pollen season were analyzed for two periods (day 1–7
and 36–42). Period (1 = day 1–7 and 2 = 36-42) was added
to the model. The estimates were obtained by the proced-
ure GENMOD in SAS.
Breaking points for the symptom score (nose, eye,
lung and total) were obtained by the fitting method
Loess in SPSS. 50% of points to fit and kernel
Epanechnikov were used.
The statistical analyses were performed in SPSS Statis-
tics 18 for Windows (IBM Corporation, Somers, NY,
USA) and SAS 9.2 for Windows (SAS Institute Inc., Cary,




98 children aged 7–18 years were enrolled into the
study. 89 (91%) completed the study. 89.8% had seasonal
allergic rhinoconjunctivitis and 60.2% suffered from sea-
sonal allergic asthma. Of the patients with rhinitis,
85.1% was classified as moderate/severe. A majority of
the rhinitis patients also had concomitant asthma
(61.5%) (Table 1).
The pollen season
The first grass pollen was registered 26 April (Figure 1).
From 5 May, grass pollen was registered on five days on
a row. On 25 May, the grass pollen count was 4 pollen
grains per cubic meter, but then, counts started to in-
crease and on 31 May, the day before the start of the
study period the pollen count was 30 pollen grains/m3.
During the study period, the pollen count varied be-
tween 1 and 242 pollen/m3. The total number of regis-
tered pollen during the study period was 2920, i.e. 79%
of the total pollen index (3700) during the entire grass
flowering period. The study period encompassed most
of the anthesis of species belonging to the subfamily
Pooideae, which are the main provokers of grass pollen
induced allergy in Sweden [18]. The peak occurred at 13
June (Figure 1), the day after a heavy rain, and counts
then did not decrease below 50 grains/m3 until 5 July.
The values for the 1st quartile, median, and 3rd quartile
were 17, 61, and 107 pollen grains per cubic meter, re-
spectively. After the end of the study period, the max-
imum daily count was 33 pollen/m3, and the weather
turned cooler with more precipitation.
Relationship between pollen count and symptoms
The breaking points for total symptom aggravation were
visually inferred from a Loess curve (Figure 2). We found
two sharp inflexion points at 30 and 80 pollen/m3, and aless clear one at 150 pollen/m3. There was a significant
relationship for the total symptom scores on pollen
count when calculated for the entire study period (p <
0.0001), the period comprising study days 8–17 (p =
0.0011), and for the period comprising study days 28–37
(p = 0.037).
Nose symptom scores increased continuously and
linearly with pollen counts from concentrations of 0–30
grains/m3 (Figure 2), wherefrom symptom severity in-
creased faster until about 80 pollen/m3. At higher pollen
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to increase. There was a dependence on pollen count
during the entire study period, during days 1–42 and
during days 8–17 (for both, p < 0.0001). During the
period days 28–37, the dependence was near significance
(p = 0.066).
Eye symptom scores increased with pollen count be-
yond concentrations of about 70 grains/m3 and did not
level out until about 140–150 pollen/m3 Two lower in-
flexion points of the curve were located at pollen con-
centrations of about 30 and about 80 pollen/m3
(Figure 2). The dependence of symptoms on pollen
count was significant when calculated for the entire
study period (p < 0.0001). For the final period (days 28–
37), the relationship was near significance (p = 0.074).
Lung symptoms scores related to increasing pollen
counts in a pattern different from that of the nose and
the eyes (Figure 2). There was no apparent change in
symptom severity until levels above 50 pollen/m3. From
levels above about 70 pollen/m3, the increase appeared
almost linear. During the period days 1–42, there was a
dependence of symptoms on pollen counts (p = 0.0025).Lag effects, accumulation of exposure effects and
symptom severity
Pollen exposure had a significant effect on nose, eyes
and lung symptoms. With an increasing lag of 1–3 days,
significance levels decreased. For lung symptoms, the ef-
fect was nearly significant (p = 0.055) for a lag of one day
but with two or three days, there was none. For nose
and eye symptoms, the effect of exposure 3 days before
symptom registration was still significant, but signifi-
cance level had decreased from p < 0.0001 for a lag of 0–
2 days to p = 0.0021 for nose and p = 0.0007 for eyes. ForFigure 1 Daily pollen grains, maximum temperatures and precipitatio
152–193) is delimited with a pale blue square.total symptoms, the significance level at a lag of 3 days
decreased to p = 0.0014.
If the day when symptoms were registered was ex-
cluded, and only accumulated pollen sum during three
days preceding this date was included, there was still a
strongly significant effect on nose, eye and total symp-
toms (p < 0.0001), but none on lung symptoms. With an
extension to five days before registration day, the effect
remained strongly significant for eye symptoms, and
significant to a lower degree for nose and total symp-
toms (p = 0.0004, and p = 0.0001, respectively).Reactivity late in pollen season
The change in reactivity to pollen exposure during the
pollen season was analysed for two periods (day 1–7 and
day 36–42). The change in symptom severity by pollen
exposure did not change significantly during the season
neither for nose, eyes, lungs and total symptom score.
Threshold levels
We considered the nose, eye, lung and total symptom
scores separately, and related symptom scores to
Swedish and British/Danish pollen warning threshold
levels (Table 2). We related them to a three-level alert
system defined from the visual inference of the Loess
curve (Figure 2), which we call the “traffic light system”
with green, yellow, and red light, in order to easily com-
municate the symptom risk level to children (Figure 3).
Lag effects, accumulation of exposure effects, and
estimation of HRQL
The mean PADQLQ score during the first study week
was 1,35 and then increased to 1.4 during the fourth
week Thereafter, the estimated scores decreased, to 1.1n in Malmö 2009. The study period 1 June–12 July (ordinal dates
Figure 2 The relationship between symptom scores and pollen grains during the study period 1 June–12 July in Malmö 2009,
evaluated with locally weighted regression (LOESS).
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and 1.0 during the last week (6th July-12th July, days
36–42), concomitant with a generally decreasing trend
in pollen concentration (Figure 4).
Pollen exposure during the days previous to the day
when HRQL was estimated had an effect on the esti-
mate, but less so, the more days that were included,
and if the pollen counts on the estimation day was ex-
cluded. The strongest effect was found for the effect of
the pollen count with a lag of 1 day (p = 0.0022). Pollen
count during the single days 2 days, and 3 days before
estimation day respectively, had no significant effects.
The accumulated effect of four days, including
registration day, or of 6 days, including estimation day,
was significant (p = 0.0024, and p = 0.0034, respect-
ively). If estimation day was excluded, and 3 days
accumulated exposure or 5 days accumulated exposure
were considered, the effects had significance levels of
p = 0.0087 and p = 0.01, respectively. Mean pollen count
during an entire week, estimation day included (days 0–6)
had a significant effect (p = 0.010) on the estimation of
HRQL score.Symptom severity over time
During the first ten days of the study, maximum symp-
tom scores varied between 7 and 8. They varied
between 8 and 9 during the period 8–28 June (when
pollen concentration levels generally was higher than
65 pollen/m3, with exception for one day with heavy
rain and another one, with 42 pollen/m3. Score sums
of 9 were recorded also towards the end of this period,
and also a couple of days later, when pollen concentra-
tion levels temporarily rose again. Thereafter, max-
imum scores varied between 6 and 7, and the very last
day, reached 5 (Figure 5).Discussion
Pollen elicits symptoms in about 1 of every five persons,
with a great effect both on individuals and on the soci-
ety. Many people suffer in their daily lives, not being
able to live the life they want, with a great effect on the
quality of life. Furthermore, in the society, there are
great costs for health care and medicine, and also a lot
of indirect costs with absence from work and school.
Table 2 Threshold levels
Symptom Threshold level Pollen grain per cubic metre level OR (95% CI) P-value
Nose Sweden Low–Medium 0.98(0.84–1.13) 0.74
Medium–High 1.42(1.19–1.69) <0.0001
High–Very high 1.24(1.07–1.44) 0.0049
Britain/Denmark Low–Medium 1.18(1.02–1.37) 0.026
Medium–High 1.37(1.16–1.61) 0.0002
High–Very high 1.04(0.88–1.24) 0.64
Traffic lights Low–Medium 1.40(1.19–1.65) <0.0001
Medium–High 1.19(1.02–1.40) 0.027
Eye Sweden Low–Medium 1.02(0.89–1.18) 0.77
Medium–High 1.34(1.10–1.61) 0.028
High–Very high 1.30(1.14–1.48) <0.0001
Britain/Denmark Low–Medium 1.12(0.96–1.31) 0.15
Medium–High 1.38(1.17–1.62) <0.0001
High–Very high 1.30(1.09–1.56) 0.0038
Traffic lights Low–Medium 1.33(1.13–1.56) 0.0007
Medium–High 1.30(1.14–1.48) <0.0001
Lung Sweden Low–Medium 0.92(0.76–1.10) 0.35
Medium–High 1.10(0.89–1.35) 0.39
High–Very high 1.27(1.13–1.43) <0.0001
Britain/Denmark Low–Medium 0.95(0.83–1.10) 0.51
Medium–High 1.21(1.03–1.43) 0.020
High–Very high 1.20(1.01–1.42) 0.041
Traffic lights Low–Medium 1.02(0.85–1.23) 0.82
Medium–High 1.27(1.12–1.45) 0.0003
Total Sweden Low–Medium 1.04(0.91–1.18) 0.57
Medium–High 1.35(1.15–1.59) 0.0003
High–Very high 1.25(1.11–1.42) 0.0004
Britain/Denmark Low–Medium 1.14(1.00–1.29) 0.046
Medium–High 1.39(1.20–1.62) <0.0001
High–Very high 1.14(0.96–1.35) 0.12
Traffic lights Low–Medium 1.36(1.18–1.58) <0.0001
Medium–High 1.25(1.10–1.42) 0.0008
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since they carry allergens. In sensitized children, these
allergens elicit an allergic reaction in the target organ
and give rise to a systemic inflammation [19]. It has re-
cently been demonstrated that pollen grains, under
physiological exposure conditions, release not only aller-
gens but also bioactive lipids and enzymes that activate
human neutrophils and eosinophils in vitro [20, 21]. In
other studies, atmospheric pollen count were found to
be positively correlated with allergic symptoms, drug
consumption for allergic rhinitis and/or conjunctivitis
[9-12], emergency visits because of asthma [22-26], andhospitalizations because of asthma [27-29]. However, not
only sensitization rates but also the severity of reactions
to the same pollen concentrations may vary between dif-
ferent regions [30]. Thus, it is important to investigate
these patterns in different populations. Moreover, most
studies have so far not investigated if the reactions
change with time, and either focus on one target organ
or lump symptoms from several organs together. In the
present study, we have found a strong relation between
symptoms, quality of life and grass pollen exposure. We
also found that different organs react differently when
pollen concentrations change, also with regard to the
Figure 3 Threshold levels in Sweden and Britain/Denmark (L = Low, M = Medium, H = High and VH = Very High), and the traffic light
model (Low, Medium and High). There was no significant change (ns) in symptom score between low and medium levels, when the Swedish
threshold levels were used, neither was the change in symptom scores between high and very high levels as defined in the British system.
* = p < 0.05, ** = p < 0.01, *** = p < 0.001.
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day. There is a lag effect of the preceding days upon eye
and nose, but not upon lung symptoms. We did not find
any signs of aggravation, nor of symptom relief over time
that could not be related to increasing or decreasing
pollen levels on the assessment day or on the preceding
three-day period.
Citizens who are well informed on factors in their en-
vironment, e.g., the presence of aerosols with a possible
adverse effect on health, are able to take measures in
order to protect themselves from these negative effects.
According to EU directives, this information should not
only comprise anthropogenic, but also natural sources of
such aerosols [31, 32]. Information about registered and
forecasted amounts of allergenic and airborne pollen
helps the allergy sufferer to identify his or her disease
and relate it to ambient concentration levels. The aller-
gic person can avoid activities that enhance exposure
risk or demand a high level of concentration and preci-
sion, and may take appropriate medication to reduce the
effects of exposure. Thus, he or she may take control of
the disease, with increased performance and quality of
life.In many countries and regions, this information ser-
vice is already running. Pollen concentration is measured
at a daily basis, and the registered numbers and/or
short-term forecasts are usually presented in media and
special web sites, usually translated to categories such as
low, moderate and high levels. The delimitation of these
categories varies from country to country. They may ei-
ther be determined according to the number of individ-
uals that experience symptoms at a certain ambient
pollen load [33], according to the severity of symptoms
in an “average” allergic person, or to the general abun-
dance of the pollen types [34]. In Malmö and other parts
of Sweden, the categories used in the public warning
system (Table 3) were delimitated in the 1970’s, referring
to “clinical experience”. The capital of Denmark,
Copenhagen is situated only a few kilometres from
Malmö, across the strait of Öresund, and a considerable
amount of inhabitants commute back and forth every
day. However, in Copenhagen, the British threshold
levels (Table 2) are used in public communication [35].
From an educational point of view, this situation is not
desirable; first, the threshold levels should be clinically






























Figure 4 Symptoms and HRQL during grass pollen season. a. Mean symptom scores and square roots of grass pollen grains during the study
period 1st June–12th July in Malmö 2009. b. Mean total PADQLQ score during the study period. The vertical lines delimit the weeks.
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of these systems, if any, reflects the clinical reactivity best.
In the children of our study group, we found three
relevant levels reflecting the reaction towards grass
pollen: at 0–30 pollen per cubic meter, giving no or
minor symptoms, at 30–80 pollen per cubic meter giving
intermediate symptoms, and then at more than 80
pollen per cubic meter causing severe symptoms
(Figure 2). We found that the Swedish system has a un-
necessary limit between “low” and “moderate” values at
10 pollen/m3, and that the British/Danish system in-
cludes a limit between “high” and “very high” levels that
do not reflect any significant differences in symptom se-
verity (Figure 3). We found that symptoms reached a
plateau at 80 pollen/m3, and we do not believe that it is
clinical meaningful to further categorize into very high
levels. A similar plateau beyond 80–90 pollen grains was
found from France and Switzerland, which suggests that
the pollen limits found in our study might be applicable
in northern and central Europe [36].Most studies on the effects of bio aerosols on health
focus on asthma exacerbations, measured as emergency
visits or hospitalizations, or on rhinoconjunctivitis.
Fewer consider symptoms from several organs at one
time. We studied total symptom scores and nose, eye
and lung symptoms separately and found that the two
former and the latter vary with pollen concentration in
different ways. The curves describing nose and eye
symptoms are steeper and have a number of more or
less sharp inflexion points, whereas the lung symptoms
do not increase until pollen concentration reaches about
70 pollen per cubic meter, and the symptom scores
where fairly low throughout our study (Figure 2). It is
possible that pollen counts must be higher to have a
clear effect on lung symptoms, or that exacerbations of
such symptoms are associated with special meteoro-
logical conditions, such as humid conditions and thun-
derstorms that may cause the pollen grains to burst.
Epidemiological studies have shown an association
between even lower levels of pollen concentrations (less
ab
Figure 5 a. Distribution of total symptom scores for each study day during the period 1 June–12 July in Malmö 2009. Each box plot is
composed of 3 horizontal lines displaying the 25th, 50th, 75 th and 90th percentiles. The dots represent outliers. b. Sum of pollen counts and
precipitation, day by day during the same period. The horizontal line denotes 80 pollen grains per cubic metre, the suggested lower limit for
“high grass pollen concentration”. Pollen counts are expressed as square roots of the actual numbers.
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suggests that these levels might have effect on suscep-
tible individuals [37]. During the present study, there
was little precipitation, with exception of one day just
before the pollen peak, and the connection between
heavy rains and lung symptoms could not be evaluated.
But pollen-derived debris and small particles can be as-
sociated with pollen allergens, and since they are much
smaller than the intact grains are themselves, they are
able to penetrate into the lower airways as to induce
asthma [38]. Furthermore, asthma is a complex disease
with many different phenotypes where pollen allergy is
only one of many factors influencing asthma control
[39]. From our results, it is apparent that even if less
dramatic, rhinoconjunctivitis must not be neglected,
since there is a clear effect on the well being and HRQL
of the involved children (Figure 4).
We found a lag effect up to 5 days. Some previous
studies have found a lag phase of 1–5 days [40, 41]. We
could not find any difference in reactivity between theTable 3 Odds Ratios for symptoms at different threshold
levels between different pollen grain levels
Threshold level (pollen grains per cubic metre)
Levels Britain/Denmark Sweden Traffic lights
Low 1–30 0–10 0–30
Moderate 31–50 11–30 31–80
High 51–150 31–100 81–
Very High 150– 101–beginning and the end of the pollen season. As early as
in the 1960’s, repeated pollen challenges were shown to
increase nasal sensitivity to other allergens in experi-
mental models. This was called Connell’s priming effect
[42]. De Weger et al. [43] found that that allergic rhinitis
symptoms at similar grass pollen concentrations were
more severe in the early flowering season as compared
to those in the late flowering season. They suggested
that there is a natural potential to down-regulate the al-
lergic response after repeated allergen exposure, similar
to the effects of successful immunotherapy. In contrast
to the results of that study, we could neither find
evidence for symptom relief, nor aggravation, during the
course of the study period that could not be related to
changes in pollen levels. The strength of our design is
that we do not have symptom aggravation in early grass
pollen season due to actual other allergen exposure (e.g.
birch pollen), since birch senstized children were
excluded.
Strengths and limitations of this study
The strength of our study is the well-characterized pa-
tient population, the wide range of symptom severity in
the children included in the study, the careful follow up
including HRQL and symptom diary with repeated
measurements.
It would have been appropriate to have monosensitized
children in order to study the effect of grass pollen expos-
ure but this was not possible since most of our population
are multisensitized. We believe that the results in the
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only symptomatic to grass pollen are valid although we
cannot exclude an underlying allergic inflammation affect-
ing the result. Also a control group would have been pre-
ferred. In this study the children are their own controls.
This has been done by assessment both in and out of sea-
son. The generalizability is limited to some degree since the
recruitment of patients was made on patients seeking help
for their pollen allergy and thus probably not representative
for the whole grass pollen allergy population. We believe
that the study population are representative for the popula-
tion seeking help for their grass pollen allergy and thus is of
great importance to study for the optimization of their
treatment.
Other factors than pollen, such as humidity, temperature
and air pollution, might also influence the result. Air pollu-
tion may be an important factor working synergistically
with pollen eliciting symptoms. Air pollutants can both
interact with pollen grains, leading to an increased release
of antigens characterized by modified allergenicity, and
affect the airways, by enhancing the contact between aller-
gens and immunoactive cells, and thus reinforce aller-
gic inflammation [31]. Particulate pollutants can
interact with allergen-carrying paucimicronic particles
derived from plants. The paucimicronic particles,
pollen-originated or not, are able to reach peripheral
airways with inhaled air, so inducing asthma in sensi-
tized subjects [38].
Grass pollen originates from several species, which are
not readily distinguished in the traditional pollen ana-
lysis. Most grass pollen allergies in Scandinavia are said
to be induced by several species within the subfamily
Pooideae, with extensive cross-allergy, but species be-
longing to other subfamilies are also present, e.g. Phrag-
mites, although the peak of their flowering is later.
When considering the effects of grass pollen, it would be
optimal to have access to more detailed phenological
information and measurements of airborne allergenic
proteins, to be able explain if changes in symptoms is re-
lated to allergen load or not. However, our study is likely
to have encompassed most of the Pooideae flowering
period and the results should reflect such a relationship.
Reactivity to other pollens, like birch, still has to be
validated.
Another limitation is the lack of medication score. The
effect of pollen exposure should also include the medica-
tion need, which can affect both symptoms and HRQL.
This is recommended in guidelines for clinical studies
[7]. In the present observational study, children had a
wide range of different medications and most of them
used their medication regularly and thus are not believed
to correlate to the burden of pollen exposure.
All the analyses presented here are conducted on
group level. Web-based individual based forecasts exists,where the patient fills in a diary to estimate the sensitiv-
ity to pollen exposure will be useful, but need to be
developed for optimal communication with different
target groups and to suit their varying reaction patterns
according to age and geographical origin.
Conclusion
Respiratory allergy is a great problem, and in case of
grass pollen allergy we find an effect on symptoms and
on HRQL, lasting up to 5 days after exposure. We nei-
ther find indications of symptom aggravation, nor allevi-
ation during the course of exposure. One cornerstone in
treatment in respiratory allergy and in pollen allergy is
the availability of pollen forecasts to make it possible to
take preventive actions. Such a system should be evi-
dence based, and easy to understand. We suggest a traf-
fic light model for public pollen warnings directed to
children, where green means “no problem”, yellow
means “can be problems, especially if you are highly sen-
sitive” and red means “alert – take action”.
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